F2G Alternatives & Competitors
12 companies similar to F2G — The rare fungal disease company
Ansun Biopharma, Inc.
Discovering solutions for the world
Actio Biosciences, Inc.
From One To Many.
Prevail Therapeutics
Wholly owned subsidiary of Eli Lilly and Company
Solid Biosciences
#TogetherWeAreSolid
Track all F2G competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
BridgeBio
We move at the speed of patient need.
GENOME INSIGHT INC.
Cancer whole genome platform company
Biogen
Innovative therapies worldwide for people living with serious neurological and neurodegene...
Ultragenyx
Going Beyond Every Day
Avidity Biosciences, Inc.
At Avidity, we are developing a new class of oligonucleotide-based therapies.
bluebird bio
Pursuing curative gene therapies to give patients and their families more bluebird days.
Spero Therapeutics
Clinical-stage biotech company focused on rare diseases and diseases with high unmet need
Neurocrine Biosciences
You Deserve Brave Science
About F2G
The rare fungal disease company
Development of Antifungal Therapies, Research and Development in Fungal Infections, Early Access to Investigational Therapies
Patients with Rare Fungal Infections, Healthcare Providers, Medical Researchers
Biopharmaceutical, Clinical-stage, Fungal Disease, Orotomides, Antifungal Agents, Invasive Fungal Infections, Dihydroorotate Dehydrogenase, Pyrimidine Biosynthesis, Olorofim, Fungicidal Activity, Rare Mould Infections, Phase 3 Trial, Orphan Drug Status, Breakthrough Therapy Designation, Proprietary Genomics Technology
B2B, B2D
Product Sales, Licensing, Service Fee
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches F2G and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at F2G on 11 Mar 2026. The 12 companies listed here were last checked between 28 Jan 2026 and 3 Jul 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.